摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine | 98088-45-0

中文名称
——
中文别名
——
英文名称
(8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine
英文别名
(6Z,8S,8aS)-6-[(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene]-8-methyloctahydro-8-indolizinol;(6Z,8S,8aS)-6-[(E,2R,6S)-2,5-dimethyl-6-phenylmethoxyoct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol
(8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine化学式
CAS
98088-45-0
化学式
C26H39NO2
mdl
——
分子量
397.601
InChiKey
ONQAZMIWMOKCRO-ZDPMLQHASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    29
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    32.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidinelithium 作用下, 以 四氢呋喃 为溶剂, 以85%的产率得到(+)-(15S)-pumiliotoxin A
    参考文献:
    名称:
    Pumiliotoxin A 和 B 的高效全合成。碘化物促进的亚胺离子-炔烃环化在生物碱构建中的应用
    摘要:
    描述了 pumiliotoxin A 生物碱全合成的实用路线。中心步骤是通过碘化物促进的亚胺鎓离子-炔环化作用形成哌啶环和建立 (Z)-亚烷基侧链。(+)-15(S)-pumiliotoxin A (2) 的全合成分 5 步实现,炔烃 36 和环氧化物 7 的总产率为 32%。2 的合成分 13 步进行,总产率为 12%( S)-2-甲基-1-戊烯-3-醇 (25) 和 8 个步骤和来自 N-[(苄氧基) 羰基]-1-脯氨酸的 9% 总产率。(+)-pumiliotoxin B (3) 的合成以四步类似的方式实现,来自炔烃 54 和环氧化物 7 的总产率为 44%。对映纯 3 的总产率为 8%,来自 N-[(苄氧基)羰基]-l -脯氨酸和 10% 来自 (4S,5R)-4-methyl-5-phenyl-2-oxazolidinone。
    DOI:
    10.1021/ja961641q
  • 作为产物:
    描述:
    (8S,8aS)-8-hydroxy-8-methyl-(6E)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-1-iodo-4-octenylidene>octahydroindolizine 在 甲醇正丁基锂 作用下, 生成 (8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine
    参考文献:
    名称:
    通过还原性亚胺离子-炔烃环化反应,对pumiliotoxin a生物碱进行对映选择性全合成。(+)-pumiliotoxin a的全合成
    摘要:
    公开了一种对映选择性合成pumiliotoxin A生物碱的高度实用的新途径,其中标题反应是关键步骤。
    DOI:
    10.1016/s0040-4039(00)82477-6
点击查看最新优质反应信息

文献信息

  • Enantioselective total synthesis of the pumiliotoxin a alkaloids via reductive iminium ion-alkyne cyclizations. Total synthesis of (+)-pumiliotoxin a
    作者:Larry E. Overman、Matthew J. Sharp
    DOI:10.1016/s0040-4039(00)82477-6
    日期:1988.1
    A highly practical new route for the enantioselective synthesis of the pumiliotoxin A alkaloids in which the title reaction is a key step is disclosed.
    公开了一种对映选择性合成pumiliotoxin A生物碱的高度实用的新途径,其中标题反应是关键步骤。
  • Total Synthesis of Pumiliotoxins A and 225F
    作者:Shintaro Hirashima、Sakae Aoyagi、Chihiro Kibayashi
    DOI:10.1021/ja991918x
    日期:1999.10.1
  • Convergent Approach to Pumiliotoxin Alkaloids. Asymmetric Total Synthesis of (+)-Pumiliotoxins A, B, and 225F
    作者:Sakae Aoyagi、Shintaro Hirashima、Kosuke Saito、Chihiro Kibayashi
    DOI:10.1021/jo0200466
    日期:2002.8.1
    (Z)-iodoalkylidene indolizidine 34, which served as a common key intermediate, was synthesized through highly stereoselective addition of the chiral silylallene 19 to (S)-acetylpyrrolidine followed by a palladium-catalyzed intramolecular carbonylation[bond]cyclization sequence. This synthetic process allowed the first total synthesis of (+)-pumiliotoxin 225F. The intermediate (Z)-iodoalkylidene indolizidine 34 obtained
    利用Pd(0)催化的均烯酸有机锌和乙烯基碘化物之间的交叉偶联反应,已经开发了一种通用的会聚方法来制备pumiliotoxin生物碱。通过将手性甲硅烷基亚烷基19高度立体选择性地加成到(S)-乙酰基吡咯烷中,然后钯催化的分子内羰基化键合环化序列,合成了用作常见关键中间体的(Z)-碘亚烷基吲哚并吡啶34。该合成过程允许(+)-pumiliotoxin 225F的第一个全合成。将获得的中间体(Z)-碘亚烷基吲哚并吡啶34转化为均烯丙基氯化锌衍生物,并使用Pd(PPh(3))(4)催化剂与(E)-乙烯基碘42进行均烯丙基-乙烯基交叉偶联,得到带有1,5-二烯侧链的交叉偶联产物47。
  • Efficient Total Syntheses of Pumiliotoxins A and B. Applications of Iodide-Promoted Iminium Ion−Alkyne Cyclizations in Alkaloid Construction
    作者:Nan-Horng Lin、Larry E. Overman、Michael H. Rabinowitz、Leslie A. Robinson、Matthew J. Sharp、Jeffery Zablocki
    DOI:10.1021/ja961641q
    日期:1996.1.1
    A practical route for the total synthesis of pumiliotoxin A alkaloids is described. The central step is formation of the piperidine ring and establishment of the (Z)-alkylidene side chain by an iodide-promoted iminium ion−alkyne cyclization. The total synthesis of (+)-15(S)-pumiliotoxin A (2) was realized in 5 steps and 32% overall yield from alkyne 36 and epoxide 7. This synthesis of 2 proceeded in
    描述了 pumiliotoxin A 生物碱全合成的实用路线。中心步骤是通过碘化物促进的亚胺鎓离子-炔环化作用形成哌啶环和建立 (Z)-亚烷基侧链。(+)-15(S)-pumiliotoxin A (2) 的全合成分 5 步实现,炔烃 36 和环氧化物 7 的总产率为 32%。2 的合成分 13 步进行,总产率为 12%( S)-2-甲基-1-戊烯-3-醇 (25) 和 8 个步骤和来自 N-[(苄氧基) 羰基]-1-脯氨酸的 9% 总产率。(+)-pumiliotoxin B (3) 的合成以四步类似的方式实现,来自炔烃 54 和环氧化物 7 的总产率为 44%。对映纯 3 的总产率为 8%,来自 N-[(苄氧基)羰基]-l -脯氨酸和 10% 来自 (4S,5R)-4-methyl-5-phenyl-2-oxazolidinone。
查看更多

同类化合物

(6E,7R,8R,8aS)-6-[(4E,6S)-6-羟基-2,5-二甲基辛-4-烯-1-亚基]-8-甲基八氢中氮茚-7,8-二醇 pumiliotoxin B pumiliotoxin B (8R,8αS)-8-hydroxy-8-methyl-6-((Z)-2(R)-methyl-hexylidene)octahydroindolizin-7-one erythro pumiliotoxin PTX-B (6Z,8S,8aS)-6-[(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene]-8-{[tert-butyl(dimethyl)silyl]oxy}-8-methyloctahydroindolizine (6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol (8R,8aS,6E)-8-Hydroxy-8-methyl-[(2R,4E,6S)-2,5-dimethyl-6-benzyloxymethyloxy-4-octenylidene]octahydroindolizin-7-done (8R,8aS)-8-hydroxy-6-[(E,2R,6S)-1-hydroxy-2,5-dimethyl-6-(phenylmethoxymethoxy)oct-4-enyl]-8-methyl-1,2,3,5,6,8a-hexahydroindolizin-7-one (+)-Allopumiliotoxin 323B' Pumiliotoxin 237A (1R,2R,9aS)-1-(benzyloxy)-2-hydroxy-3(E)-isobutylidene-1-methyloctahydroquinolizine (7S,8R,8aS)-8-(benzyloxy)-7-hydroxy-8-methyl-6-(E)-<(2R)-2-methylpentylidene>octahydroindolizidine (+)-allopumiliotoxin 267 A (+)-Pumiliotoxin 251D (3E)-(5S,6S)-5-hydroxy-3-[(R)-2-methylhexylidene]-5-methylazabicyclo[4.3.0]nonan-2-one (8S,8aS)-8-hydroxy-8-methyl-6(Z)-<2(R)-methylhexylidene>octahydro-5-indolizidinone (8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine (+)-(15S)-pumiliotoxin A (+)-allopumiliotoxin 339A (6E,7S,8R,8aS)-8-methyl-6-[(E,2R)-2-methyl-5-[(4R,5R)-2,2,5-trimethyl-1,3-dioxolan-4-yl]hex-4-enylidene]-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (+)-allopumiliotoxin 339 B (7R,8R,8aS)-8-(benzyloxy)-7-hydroxy-6(Z)-<6(R),7(R)-(isopropylidenedioxy)-2(R),5-dimethyl-4(E)-octenylidene>-8-methyloctahydroindolizine (+)-homopumiliotoxin 223G (6Z)-8-methyl-6-(2-methylhexylidene)-1,2,3,5,7,8a-hexahydroindolizine-7,8-diol (7R,8R,8aS,E)-6-((2R,6R,7R,E)-6,7-Dihydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol (8S,8aS)-6-[2,2-Dimethyl-hex-(Z)-ylidene]-8-methyl-octahydro-indolizin-8-ol (R,4E,8E)-8-((7R,8R,8aS)-7,8-Dihydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-en-3-one (4E,7R,8Z)-8-((1S,9aS)-1-Hydroxy-1-methyltetrahydro-1H-quinolizin-3(2H,4H,6H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol (1S,9aS,Z)-3-((2R,E)-7-Hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-1H-quinolizin-1-ol (1S,9aS,Z)-3-((2R,E)-6-Hydroxy-2,5-dimethylnon-4-en-1-ylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-6-((R,4E,6E)-2,5-Dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol (8S,Z)-6-((2R,E)-6-Hydroxy-2,5-dimethylhept-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol (R,Z)-6-((8S,8aS)-8-Hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-5-methylhexan-2-one (8S,8aS,Z)-6-((2R)-4-Hydroxy-2-methylpentylidene)-8-methyloctahydroindolizin-8-ol (1S,9aS,Z)-3-((S)-3-Hydroxy-2-methylpropylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-8-Methyl-6-((R)-2-methylpentylidene)octahydroindolizin-8-ol (6E)-8-methyl-6-(2-methylhexylidene)-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (6Z)-6-[(E)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol (8S,8aS,Z)-6-((2R)-5-Hydroxy-2-methylhexylidene)-8-methyloctahydroindolizin-8-ol Allopumiliotoxin 253a (8R,8aS,E)-6-((2R,6R,E)-6-Hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol Pumiliotoxin 309a (6E)-8-methyl-6-(2-methylhexylidene)-1,2,3,5,7,8a-hexahydroindolizine-7,8-diol (+)-Pumiliotoxin B 8-Methyl-6-(2-methylhexylidene)-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (1S,9aS,Z)-3-((2R)-6-Hydroxy-2,5-dimethyloctylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-6-((R)-7-Hydroxy-2-methylheptylidene)-8-methyloctahydroindolizin-8-ol (8S,8aS,Z)-6-((R,E)-2,5-Dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol (8S,8aS,Z)-8-Methyl-6-((R,E)-2-methyl-5-((4R,5S)-2,2,5-trimethyl-1,3,2-dioxasilolan-4-yl)hex-4-en-1-ylidene)octahydroindolizin-8-ol